| Arthur Ng, MD | |
|
1 Brace Rd Ste H, Cherry Hill, NJ 08034-2600 | |
| (856) 547-0389 | |
| Not Available |
| Full Name | Arthur Ng |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 36 Years |
| Location | 1 Brace Rd Ste H, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053352534 | NPI | - | NPPES |
| 7056303 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 25MA06433800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Home Care At West Jersey | Mount laurel, NJ | Home health agency |
| Virtua Our Lady Of Lourdes Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
In a growing number of industries, workers are often unknowingly exposed to nanoparticles (NPs). Do they enter the body? Could they have an impact on health? Professor Denis Girard from the INRS-Institut Armand-Frappier Research Centre has had the foresight to study the potential toxicity of a wide variety of NPs with a view to setting the record straight before problems occur.
LigoCyte Pharmaceuticals, Inc., a private, clinical-stage biopharmaceuticals company developing innovative vaccine products, today announced positive results from a Phase I/II challenge study of its norovirus virus-like particle (VLP) vaccine candidate.
The American Association for Dental Research (AADR) has announced that John Greenspan, University of California, San Francisco (UCSF), is the recipient of the 2010 AADR Distinguished Scientist Award. This award will be presented to Greenspan at the 39th AADR Annual Meeting & Exhibition in Washington, DC, March 3, 2010.
Using practical nano-DDS technology, a polymeric nanomicelle that effectively delivers the potent mitotic inhibitor desacetyl vinblastine hydrazide (DAVBNH) to glioblastoma (GBM) was developed.
› Verified 1 days ago
| Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
In a growing number of industries, workers are often unknowingly exposed to nanoparticles (NPs). Do they enter the body? Could they have an impact on health? Professor Denis Girard from the INRS-Institut Armand-Frappier Research Centre has had the foresight to study the potential toxicity of a wide variety of NPs with a view to setting the record straight before problems occur.
LigoCyte Pharmaceuticals, Inc., a private, clinical-stage biopharmaceuticals company developing innovative vaccine products, today announced positive results from a Phase I/II challenge study of its norovirus virus-like particle (VLP) vaccine candidate.
The American Association for Dental Research (AADR) has announced that John Greenspan, University of California, San Francisco (UCSF), is the recipient of the 2010 AADR Distinguished Scientist Award. This award will be presented to Greenspan at the 39th AADR Annual Meeting & Exhibition in Washington, DC, March 3, 2010.
Using practical nano-DDS technology, a polymeric nanomicelle that effectively delivers the potent mitotic inhibitor desacetyl vinblastine hydrazide (DAVBNH) to glioblastoma (GBM) was developed.
› Verified 1 days ago
| Entity Name | Deborah Cardiovascular Group, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821041732 PECOS PAC ID: 7618962549 Enrollment ID: O20040419001227 |
News Archive
In a growing number of industries, workers are often unknowingly exposed to nanoparticles (NPs). Do they enter the body? Could they have an impact on health? Professor Denis Girard from the INRS-Institut Armand-Frappier Research Centre has had the foresight to study the potential toxicity of a wide variety of NPs with a view to setting the record straight before problems occur.
LigoCyte Pharmaceuticals, Inc., a private, clinical-stage biopharmaceuticals company developing innovative vaccine products, today announced positive results from a Phase I/II challenge study of its norovirus virus-like particle (VLP) vaccine candidate.
The American Association for Dental Research (AADR) has announced that John Greenspan, University of California, San Francisco (UCSF), is the recipient of the 2010 AADR Distinguished Scientist Award. This award will be presented to Greenspan at the 39th AADR Annual Meeting & Exhibition in Washington, DC, March 3, 2010.
Using practical nano-DDS technology, a polymeric nanomicelle that effectively delivers the potent mitotic inhibitor desacetyl vinblastine hydrazide (DAVBNH) to glioblastoma (GBM) was developed.
› Verified 1 days ago
| Entity Name | Stafford Medical, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558382457 PECOS PAC ID: 2466434451 Enrollment ID: O20040603000555 |
News Archive
In a growing number of industries, workers are often unknowingly exposed to nanoparticles (NPs). Do they enter the body? Could they have an impact on health? Professor Denis Girard from the INRS-Institut Armand-Frappier Research Centre has had the foresight to study the potential toxicity of a wide variety of NPs with a view to setting the record straight before problems occur.
LigoCyte Pharmaceuticals, Inc., a private, clinical-stage biopharmaceuticals company developing innovative vaccine products, today announced positive results from a Phase I/II challenge study of its norovirus virus-like particle (VLP) vaccine candidate.
The American Association for Dental Research (AADR) has announced that John Greenspan, University of California, San Francisco (UCSF), is the recipient of the 2010 AADR Distinguished Scientist Award. This award will be presented to Greenspan at the 39th AADR Annual Meeting & Exhibition in Washington, DC, March 3, 2010.
Using practical nano-DDS technology, a polymeric nanomicelle that effectively delivers the potent mitotic inhibitor desacetyl vinblastine hydrazide (DAVBNH) to glioblastoma (GBM) was developed.
› Verified 1 days ago
| Entity Name | Humc Cardiovascular Partners, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417188905 PECOS PAC ID: 6406996503 Enrollment ID: O20091222000199 |
News Archive
In a growing number of industries, workers are often unknowingly exposed to nanoparticles (NPs). Do they enter the body? Could they have an impact on health? Professor Denis Girard from the INRS-Institut Armand-Frappier Research Centre has had the foresight to study the potential toxicity of a wide variety of NPs with a view to setting the record straight before problems occur.
LigoCyte Pharmaceuticals, Inc., a private, clinical-stage biopharmaceuticals company developing innovative vaccine products, today announced positive results from a Phase I/II challenge study of its norovirus virus-like particle (VLP) vaccine candidate.
The American Association for Dental Research (AADR) has announced that John Greenspan, University of California, San Francisco (UCSF), is the recipient of the 2010 AADR Distinguished Scientist Award. This award will be presented to Greenspan at the 39th AADR Annual Meeting & Exhibition in Washington, DC, March 3, 2010.
Using practical nano-DDS technology, a polymeric nanomicelle that effectively delivers the potent mitotic inhibitor desacetyl vinblastine hydrazide (DAVBNH) to glioblastoma (GBM) was developed.
› Verified 1 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
In a growing number of industries, workers are often unknowingly exposed to nanoparticles (NPs). Do they enter the body? Could they have an impact on health? Professor Denis Girard from the INRS-Institut Armand-Frappier Research Centre has had the foresight to study the potential toxicity of a wide variety of NPs with a view to setting the record straight before problems occur.
LigoCyte Pharmaceuticals, Inc., a private, clinical-stage biopharmaceuticals company developing innovative vaccine products, today announced positive results from a Phase I/II challenge study of its norovirus virus-like particle (VLP) vaccine candidate.
The American Association for Dental Research (AADR) has announced that John Greenspan, University of California, San Francisco (UCSF), is the recipient of the 2010 AADR Distinguished Scientist Award. This award will be presented to Greenspan at the 39th AADR Annual Meeting & Exhibition in Washington, DC, March 3, 2010.
Using practical nano-DDS technology, a polymeric nanomicelle that effectively delivers the potent mitotic inhibitor desacetyl vinblastine hydrazide (DAVBNH) to glioblastoma (GBM) was developed.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arthur Ng, MD 301 Lippincott Dr Ste 120, Marlton, NJ 08053-4197 Ph: () - | Arthur Ng, MD 1 Brace Rd Ste H, Cherry Hill, NJ 08034-2600 Ph: (856) 547-0389 |
News Archive
In a growing number of industries, workers are often unknowingly exposed to nanoparticles (NPs). Do they enter the body? Could they have an impact on health? Professor Denis Girard from the INRS-Institut Armand-Frappier Research Centre has had the foresight to study the potential toxicity of a wide variety of NPs with a view to setting the record straight before problems occur.
LigoCyte Pharmaceuticals, Inc., a private, clinical-stage biopharmaceuticals company developing innovative vaccine products, today announced positive results from a Phase I/II challenge study of its norovirus virus-like particle (VLP) vaccine candidate.
The American Association for Dental Research (AADR) has announced that John Greenspan, University of California, San Francisco (UCSF), is the recipient of the 2010 AADR Distinguished Scientist Award. This award will be presented to Greenspan at the 39th AADR Annual Meeting & Exhibition in Washington, DC, March 3, 2010.
Using practical nano-DDS technology, a polymeric nanomicelle that effectively delivers the potent mitotic inhibitor desacetyl vinblastine hydrazide (DAVBNH) to glioblastoma (GBM) was developed.
› Verified 1 days ago
Dr. Arthur Allan Hellman, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 940 Brick Rd, Cherry Hill, NJ 08003 Phone: 856-489-3624 | |
Atiq Ur Rehman, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd, Suite C, Cherry Hill, NJ 08034 Phone: 856-470-9029 Fax: 856-428-4053 | |
Dr. Andrew S Olearchyk, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 129 Walt Whitman Blvd, Cherry Hill, NJ 08003 Phone: 856-428-0505 Fax: 856-428-0505 | |
Dr. Salvatore Michael Moffa, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 3207 Bishops View Cir, Cherry Hill, NJ 08002 Phone: 856-910-2850 | |
Chun W Choi, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd Ste H, Cherry Hill, NJ 08034 Phone: 856-547-0389 |